论文部分内容阅读
本院于1993年3月～1997年3月应用静脉滴注人血丙种球蛋白(IVIG)预防反复呼吸道感染(RRTI)200例,取得显著疗效,现报告如下。 临床资料 观察组200例及同时期RRTI患儿100例(对照组),均按1987年全国小儿呼吸道疾病会议的诊断标准确诊全部病例均为本院门诊及住院患儿,其中男192例,女108例IVIG组男130例,女70例;对照组男62例,女38例。年龄分布:3个月～6岁,最多见于6个月～3岁,中位年龄1岁4个月。两组病例临床症状体征:畏寒、发热、鼻塞、流涕、乏力、纳差
The hospital from March 1993 to March 1997 intravenous infusion of human blood gamma globulin (IVIG) prevention and treatment of recurrent respiratory tract infection (RRTI) 200 cases, and achieved significant results are as follows. Clinical data 200 cases of observation group and 100 cases of RRTI in the same period (control group), were diagnosed according to the diagnostic criteria of the National Pediatric Respiratory Disease Conference in 1987. All patients were outpatients and hospitalized children, including 192 males and ‧ females 108 cases of IVIG male 130 cases, 70 females; control group, 62 males and 38 females. Age distribution: 3 months to 6 years old, most seen in 6 months to 3 years old, the median age of 1 year and 4 months. Clinical symptoms and signs of two groups of patients: chills, fever, nasal congestion, runny nose, fatigue, anorexia